期刊
VASCULAR PHARMACOLOGY
卷 112, 期 -, 页码 42-53出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.vph.2018.08.009
关键词
Aging; Cardiovascular diseases; Endothelial cells; Nrf2; Senescence; Vascular system
资金
- National Science Center [2016/22/E/NZ3/00405, DEC-2015/16/S/NZ4/00040]
- Ministry of Science and Higher Education
Aging is the most critical risk factor for the development of cardiovascular diseases and their complications. Therefore, the fine-tuning of cellular response to getting older is an essential target for prospective therapies in cardiovascular medicine. One of the most promising targets might be the transcription factor Nrf2, which drives the expression of cytoprotective and antioxidative genes. Importantly, Nrf2 expression correlates with potential lifespan in rodents. However, the effect of Nrf2 activity in vascular diseases might be ambiguous and strongly depend on the cell type. On the one hand, the Nrf2 activity may protect cells from oxidative stress and senescence, on the other hand, total lack of Nrf2 is protective against atherosclerosis development. Therefore, this review aims to discuss the current knowledge on the role played by the transcription factor Nrf2 in cardiovascular diseases and its potential effects on aging.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据